Promising research studies surrounding this compound, specifically the 120 milligram formulation referred to as ZPHC, indicate a significant effect on physique decrease and linked chronic illnesses . Scientists believe that this dual acting , affecting both GLP-1 and GIP receptors , has the potential to represent a noteworthy breakthrough in the m